Literature DB >> 8783415

Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis.

I Ertenli1, I C Haznedaroğlu, S Kiraz, I Celik, M Calgüneri, S Kirazhi.   

Abstract

Particular interleukins, namely interleukin (IL)-6, IL-4 and IL-1, with pro-inflammatory mediator activities have also been shown to be involved in the regulation of megakaryocytopoiesis. As rheumatoid arthritis (RA) is not uncommonly associated with reactive thrombocytosis, we investigated serum IL-1 alpha, IL-1 beta, IL-4 and IL-6 concentrations in RA patients with marked thrombocytosis, and compared them to the levels in RA patients with normal platelet counts and healthy volunteers. IL-1 beta. IL-4 and IL-6 concentrations were found to be correlated with the disease activity in both groups of RA patients, with higher serum levels of each cytokine in the thrombocythaemic group. Significant positive correlations of IL-1 beta and IL-4 with the platelet counts were documented only in patients with thrombocytosis. According to our results. IL-6 and IL-1 beta were found to be good indicators of disease activity in RA, while IL-1 beta and IL-4 seemed to be related more with the process of reactive thrombocytosis secondary to rheumatoid inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783415     DOI: 10.1007/bf01419947

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  The interleukins.

Authors:  S B Mizel
Journal:  FASEB J       Date:  1989-10       Impact factor: 5.191

2.  Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis.

Authors:  P Miossec; M Naviliat; A Dupuy d'Angeac; J Sany; J Banchereau
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  Interleukin-4 and its receptor; modulating effects on immature and mature hematopoietic cells.

Authors:  E Vellenga; W Dokter; R M Halie
Journal:  Leukemia       Date:  1993-08       Impact factor: 11.528

Review 4.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

5.  Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.

Authors:  R Madhok; A Crilly; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Elevated serum interleukin-6 levels in patients with reactive thrombocytosis.

Authors:  C W Hollen; J Henthorn; J A Koziol; S A Burstein
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

7.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

Review 8.  Megakaryocytopoiesis: the state of the art.

Authors:  A M Gewirtz
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

9.  Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells.

Authors:  H Suzuki; E Sugiyama; I S Tunru; N Yamashita; H Matsuno; T Hamazaki; M Kobayashi
Journal:  Clin Immunol Immunopathol       Date:  1993-01

10.  Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis.

Authors:  R Luqmani; T Sheeran; M Robinson; K Richardson; J Winkles; P Emery
Journal:  Clin Exp Rheumatol       Date:  1994 Sep-Oct       Impact factor: 4.473

View more
  6 in total

1.  A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis.

Authors:  Manas Talukdar; Gopinath Barui; Anjan Adhikari; Rupam Karmakar; Udas Chandra Ghosh; Tushar Kanti Das
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.

Authors:  B Hodkinson; E Musenge; M Ally; P W A Meyer; R Anderson; M Tikly
Journal:  Clin Rheumatol       Date:  2011-12-02       Impact factor: 2.980

Review 3.  Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature.

Authors:  Batya B Davidovici; Mary M Sullivan-Whalen; Patricia Gilleaudeau; James G Krueger
Journal:  BMC Dermatol       Date:  2010-03-31

Review 4.  Pathologic thrombopoiesis of rheumatoid arthritis.

Authors:  Ihsan Ertenli; Sedat Kiraz; M Akif Oztürk; Ibrahim c Haznedaroğlu; Ismail Celik; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-02-11       Impact factor: 2.631

5.  Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity.

Authors:  Özlem Taşoğlu; Ali Şahin; Gülşah Karataş; Engin Koyuncu; İrfan Taşoğlu; Osman Tecimel; Neşe Özgirgin
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

6.  Accelerated Spatial Fibrin Growth and Impaired Contraction of Blood Clots in Patients with Rheumatoid Arthritis.

Authors:  Alina D Peshkova; Tatiana A Evdokimova; Timur B Sibgatullin; Fazoil I Ataullakhanov; Rustem I Litvinov; John W Weisel
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.